NASH and Systemic Complications: From Basic to Clinical Research

Sabine Baumgartner; Ronit Shiri-Sverdlov

doi:10.3390/biomedicines9121913

NASH and Systemic Complications: From Basic to Clinical Research

Biomedicines. 2021 Dec 14;9(12):1913. doi: 10.3390/biomedicines9121913.

Authors

Sabine Baumgartner¹, Ronit Shiri-Sverdlov²

Affiliations

¹ Department of Nutrition and Movement Sciences, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
² Department of Molecular Genetics, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is known as the hepatic manifestation of the metabolic syndrome, and while most patients develop simple steatosis, up to one-third can develop nonalcoholic steatohepatitis (NASH) [...].

Publication types

Editorial